Varicella in non-immune persons: incidence, hospitalization and mortality rates, Epidemiol. Infect, vol.129, pp.599-606, 2002. ,
Varicella in Americans from NHANES III: implications for control through routine immunization, J. Med. Virol, vol.70, pp.111-118, 2003. ,
Viral Infections of Humans: Epidemiology and Control. Fourth Edition, p.1083, 1997. ,
An outbreak of airborne nosocomial varicella, Pediatrics, vol.70, pp.550-556, 1982. ,
Severe complications of varicella in previously healthy children in Germany: a 1-year survey, Pediatrics, vol.108, pp.1-6, 2001. ,
The epidemiology of varicella and its complications, J. Infect. Dis, vol.172, pp.706-712, 1995. ,
Epidemiology of varicella zoster virus infection in Canada and the United Kingdom, Epidemiol. Infect, vol.127, issue.2, pp.305-314, 2001. ,
Caractéristiques cliniques des varicelles hospitalisées en réanimation pédiatrique de, BEH, vol.09, pp.51-52, 1998. ,
ré-évaluation des recommandations relatives à la vaccination contre la varicelle avec l'arrivée de vaccins quadrivalents rougeole-rubéole-oreillons-varicelle, 2007. ,
Outcome after maternel varicella infection in the first 20 weeks of pregnancy, N. Engl. J. Med, vol.330, pp.901-905, 1994. ,
Infections virales et toxoplasmose materno, pp.73-86, 2001. ,
Deaths from varicella in infants, Pediatr Infect Dis J, vol.4, pp.503-507, 1985. ,
Varicella: complications and costs, Pediatrics, vol.78, pp.728-735, 1986. ,
Herpes zoster: burden of disease in France, Vaccine, vol.8, pp.7933-7938, 2010. ,
The nature of herpes zoster: a long-term study and a new hypothesis, Proc. R. Soc. Med, vol.58, pp.9-20, 1965. ,
Characteristics of patients with herpes zoster on presentation to practitioners in France, Clin. Infect. Dis, vol.33, pp.62-69, 2001. ,
Risk factors for postherpetic neuralgia, Arch. Intern. Med, vol.157, p.12171224, 1997. ,
Prevalence of postherpetic neuralgia after a first episode of herpes zoster: prospective study with long term follow up, BMJ, vol.321, p.7946, 2000. ,
Live Oka/Merck varicella vaccine in healthy children, JAMA, vol.254, pp.2435-2439, 1985. ,
Effectiveness over time of varicella vacine, JAMA, vol.291, pp.851-855, 2004. ,
Live attenuated varicella virus vaccine: efficacy trial in healthy children, N. Engl. J. Med, vol.310, pp.1409-1415, 1984. ,
Immunization of healthy adults with live attenuated varicella vaccine, J. Infect. Dis, vol.158, pp.132-137, 1988. ,
Immunogenicity and safety of a live attenuated varicella vaccine (Oka/SB Bio) in healthy children, J. Infect. Dis, vol.174, issue.3, pp.324-329, 1996. ,
Merck varicella vaccine in healthy children: final report of a 2 year efficacy study and 7-year follow-up studies, Vaccine, vol.9, pp.643-647, 1991. ,
Varicella vaccine in post-exposure prophylaxis, Commun. Dis. Intell, vol.25, issue.1, pp.13-15, 2001. ,
Prevention of varicella: recommendations of the Advisory Committee on Immunization Practices (ACIP) MMWR Recomm ,